Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism

Impact of Soluble Epoxide Hydrolase and Epoxyeicosanoids on Human Health

(2012) Christophe Morisseau et al.   Annual Review of Pharmacology and Toxicology

Epoxyeicosatrienoic Acid Pathway in Human Health and Diseases

(2012) Jeremy Bellien et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Epoxides and Soluble Epoxide Hydrolase in Cardiovascular Physiology

(2012) John D. Imig   PHYSIOLOGICAL REVIEWS

Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance

(2011) A. Luria et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epoxyeicosatrienoic Acid Analogs and Vascular Function

(2010) V. Sudhahar et al.   CURRENT MEDICINAL CHEMISTRY

Pharmacological inhibition of the soluble epoxide hydrolase—from mouse to man

(2010) Marc Revermann   CURRENT OPINION IN PHARMACOLOGY

Distribution and Expression of Soluble Epoxide Hydrolase in Human Brain

(2008) Priyanka Sura et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Protein Quaternary Structure and Expression Levels Contribute to Peroxisomal-Targeting-Sequence-1-Mediated Peroxisomal Import of Human Soluble Epoxide Hydrolase

(2008) Beibei Luo et al.   JOURNAL OF MOLECULAR BIOLOGY

Microsomal epoxide hydrolase deletion enhances tyrosine hydroxylase phosphorylation in mice after MPTP treatment

(2008) Mei Liu et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia

(2008) Wenri Zhang et al.   STROKE